PL409542A1 - Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwów - Google Patents
Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwówInfo
- Publication number
- PL409542A1 PL409542A1 PL409542A PL40954212A PL409542A1 PL 409542 A1 PL409542 A1 PL 409542A1 PL 409542 A PL409542 A PL 409542A PL 40954212 A PL40954212 A PL 40954212A PL 409542 A1 PL409542 A1 PL 409542A1
- Authority
- PL
- Poland
- Prior art keywords
- neuritis
- pharmaceutical combination
- compositions against
- vitamin
- antiepileptic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010029240 Neuritis Diseases 0.000 title 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 3
- 230000003556 anti-epileptic effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 229960001816 oxcarbazepine Drugs 0.000 abstract 1
- CTRLABGOLIVAIY-UHFFFAOYSA-N oxcarbazepine Chemical compound C1C(=O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 CTRLABGOLIVAIY-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 229940046001 vitamin b complex Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Wynalazek dotyczy farmaceutycznej kombinacji dwóch przeciwpadaczkowych substancji jak również kombinacji przeciwpadaczkowego leku i kompleksu witamin B, w której przeciwpadaczkowe substancje są wybrane z pregabaliny i okskarbazepiny, a witaminy są wybrane z witaminy B1 i witaminy B12. Wynalazek dotyczy również kompozycji farmaceutycznych zawierających rzeczone kombinacje i zastosowania wybranych kompozycji do leczenia bólu neuropatycznego.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2011/014042 | 2011-12-16 | ||
MX2011014042A MX336979B (es) | 2011-12-16 | 2011-12-16 | Combinacion farmaceutica antineuritica y composiciones. |
PCT/IB2012/057345 WO2013088410A1 (es) | 2011-12-16 | 2012-12-14 | Combinación farmacéutica antineurítica y composiciones |
Publications (2)
Publication Number | Publication Date |
---|---|
PL409542A1 true PL409542A1 (pl) | 2015-07-20 |
PL231163B1 PL231163B1 (pl) | 2019-01-31 |
Family
ID=48611941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL409542A PL231163B1 (pl) | 2011-12-16 | 2012-12-14 | Kombinacja i kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu bólowi z powodu umiarkowanych do ciężkich neuralgii o różnorodnym umiejscowieniu |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140323428A1 (pl) |
BR (1) | BR112014014774A2 (pl) |
CA (1) | CA2859487C (pl) |
CL (1) | CL2014001581A1 (pl) |
CO (1) | CO6990712A2 (pl) |
CR (1) | CR20140283A (pl) |
DO (1) | DOP2014000134A (pl) |
ES (1) | ES2525952B1 (pl) |
GT (1) | GT201400115A (pl) |
MX (1) | MX336979B (pl) |
NI (1) | NI201400058A (pl) |
PE (1) | PE20141688A1 (pl) |
PL (1) | PL231163B1 (pl) |
WO (1) | WO2013088410A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2826470B1 (en) * | 2013-07-19 | 2017-09-06 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of pregabalin |
MX2014008336A (es) | 2014-07-07 | 2016-01-07 | Pptm Internat S A R L | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070007276A (ko) * | 2003-12-29 | 2007-01-15 | 제이슨 맥데빗 | 재발성 의학적 증상을 치료하기 위한 조성물 및 방법 |
CA2701838A1 (en) * | 2007-10-09 | 2009-04-16 | Merck Patent Gmbh | Pharmaceutical compositions containing benfotiamine and one or more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
-
2011
- 2011-12-16 MX MX2011014042A patent/MX336979B/es active IP Right Grant
-
2012
- 2012-12-14 US US14/365,988 patent/US20140323428A1/en not_active Abandoned
- 2012-12-14 ES ES201490063A patent/ES2525952B1/es not_active Expired - Fee Related
- 2012-12-14 PL PL409542A patent/PL231163B1/pl unknown
- 2012-12-14 BR BR112014014774A patent/BR112014014774A2/pt not_active Application Discontinuation
- 2012-12-14 PE PE2014000973A patent/PE20141688A1/es active IP Right Grant
- 2012-12-14 CA CA2859487A patent/CA2859487C/en active Active
- 2012-12-14 WO PCT/IB2012/057345 patent/WO2013088410A1/es active Application Filing
-
2014
- 2014-06-16 CL CL2014001581A patent/CL2014001581A1/es unknown
- 2014-06-16 CO CO14129791A patent/CO6990712A2/es unknown
- 2014-06-16 DO DO2014000134A patent/DOP2014000134A/es unknown
- 2014-06-16 NI NI201400058A patent/NI201400058A/es unknown
- 2014-06-16 CR CR20140283A patent/CR20140283A/es unknown
- 2014-06-16 GT GT201400115A patent/GT201400115A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20140323428A1 (en) | 2014-10-30 |
ES2525952A1 (es) | 2015-01-02 |
GT201400115A (es) | 2017-07-27 |
CO6990712A2 (es) | 2014-07-10 |
PE20141688A1 (es) | 2014-12-03 |
CA2859487C (en) | 2016-11-15 |
MX2011014042A (es) | 2013-06-17 |
CL2014001581A1 (es) | 2014-09-26 |
CA2859487A1 (en) | 2013-06-20 |
NI201400058A (es) | 2014-12-22 |
ES2525952B1 (es) | 2015-10-05 |
DOP2014000134A (es) | 2014-07-31 |
WO2013088410A1 (es) | 2013-06-20 |
BR112014014774A2 (pt) | 2017-06-13 |
CR20140283A (es) | 2015-03-11 |
MX336979B (es) | 2016-02-09 |
PL231163B1 (pl) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2015000278A1 (en) | Autotaxin inhibitors | |
NI201400032A (es) | Piridopirazinas anticancerígenas via la | |
PH12016500094A1 (en) | Autotaxin inhibitors | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
WO2012174158A3 (en) | Administration of benzodiazepine | |
MX2015004604A (es) | Antagonistas de los receptores metabotropicos de glutamato 2/3 (mglu2/3) para el tratamiento de los trastornos autistas. | |
AU2012347200A8 (en) | Tablet capable of combatting misuse by injection | |
PH12014502032A1 (en) | Treatment of brain cancer | |
MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
MX357284B (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
EA201791219A1 (ru) | Антибактериальные композиции, имеющие широкий спектр активности | |
PH12016500124A1 (en) | Via antagonists to treat phase shift sleep disorders | |
MX364528B (es) | Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas. | |
MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
PL409542A1 (pl) | Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwów | |
IN2014DN03010A (pl) | ||
EP3326628A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH HIGH-CONCENTRATED TAXAN | |
MX361369B (es) | Modificaciones cristalinas estables de cloruro de dotap. | |
WO2014122671A3 (en) | Solid oral compositions of saxagliptin | |
EP3326652A4 (en) | Pharmaceutical composition for oral administration comprising high concentration taxane | |
MX2014004742A (es) | Nuevos agentes antibacterianos de fenicol. | |
GEP20135745B (en) | Drug for pyodermia treatment | |
UA97054C2 (ru) | Способ комплексного лечения больных с зависимостью вследствие употребления психоактивных веществ | |
PL402030A1 (pl) | Nowe pochodne tiosemikarbazonów, ich kompozycje farmaceutyczne oraz ich zastosowanie |